Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5020347 | 0.87 | TGFBR1 (0.36) | FFAR1TGFBR1 | |
| SCHEMBL5020230 | 0.85 | FFAR1 (0.31) | FFAR1 | |
| SCHEMBL5020228 | 0.84 | FFAR1 (0.41) | FFAR1TGFBR1 | |
| SCHEMBL5020448 | 0.84 | HSP90AA1 (0.34) | — | |
| SCHEMBL5020348 | 0.83 | TGFBR1 (0.34) | FFAR1TGFBR1 | |
| SCHEMBL5020229 | 0.82 | TGFBR1 (0.34) | FFAR1TGFBR1 | |
| SCHEMBL15465604 | 0.82 | GRM5 (0.34) | — | |
| SCHEMBL15465601 | 0.82 | GRM5 (0.34) | — | |
| SCHEMBL5020221 | 0.82 | GRM5 (0.34) | — | |
| SCHEMBL5020443 | 0.82 | HSP90AA1 (0.35) | FFAR1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
| WO-2012062844-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | MSR1, CD209, C3AR1 | FFAR1 629/4885TGFBR1 1875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.